Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Portal Monaco.
Press releases published on April 3, 2025
BOSS Revolution Announces Savings Pass – A Monthly Membership Plan
GlobeNewswire
·
April 3, 2025
Savings Pass, along with BOSS Unlimited and Bundles of Minutes monthly calling plans, offer spectacular savings no matter where you call or how long you talk NEWARK, NJ, April 03, 2025 (GLOBE NEWSWIRE) -- BOSS Revolution, the popular provider of …
Brag House Expresses Confidence in Strategy and Comments on Recent Trading Activity
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH), a pioneering media-tech platform at the intersection of gaming, college sports, and brand engagement, today expressed confidence in its strategy and commented on recent …
BetterLife Pharma Appoints Corporate Advisor
GlobeNewswire
·
April 3, 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed André Beaudry as Corporate …
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline
GlobeNewswire
·
April 3, 2025
- The oversubscribed private financing round, with primary participation from Fidelity Management …
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
GlobeNewswire
·
April 3, 2025
-- Novel, locally administered gene therapy designed to boost cellular production of anti-inflammatory protein IL-1Ra in the knee -- -- Initial topline results from two-part, randomized, double-blind, active-controlled study expected late 2026 -- BRISBANE, …
CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 3, 2025
ZUG, Switzerland and BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior …
March Commercial Chapter 11s Increase 20 Percent from Previous Year
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Commercial chapter 11 bankruptcy filings increased 20 percent in March 2025, with filings climbing to 733 from the 611 filings registered in March 2024, according to data provided by Epiq AACER, the leading …
American Rebel Holdings, Inc. (NASDAQ: AREB) Invites Patriotic Investors, Fans, and Beer Enthusiasts to Celebrate Freedom with a New Video Release Highlighting the American Rebel Story
GlobeNewswire
·
April 3, 2025
Watch the American Rebel Story and learn about America’s Next Great Company as told by CEO Andy Ross Nashville, TN, April 03, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB), the creator of American Rebel Beer and champion of …
Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301
GlobeNewswire
·
April 3, 2025
KANSAS CITY, Kan., April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation …
Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy
GlobeNewswire
·
April 3, 2025
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the first patient has been dosed …
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
GlobeNewswire
·
April 3, 2025
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified …
Auron Presents New Preclinical Data for AUTX-703 in Small Cell Lung Cancer (SCLC)
GlobeNewswire
·
April 3, 2025
NEWTON, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced data from a poster presentation …
Lianhe Sowell International Group Ltd Announces Pricing of Initial Public Offering
GlobeNewswire
·
April 3, 2025
Shenzhen, China, April 03, 2025 (GLOBE NEWSWIRE) -- Lianhe Sowell International Group Ltd (the “Company”), a provider of machine vision products and solutions applied in a wide range of businesses across industries in China, today announced the pricing of …
Breaking News: Early Clinical Trial on Plant-Based Finasteride Alternative Shows Exciting Results Amid Growing Concerns Over Drug Side Effects
GlobeNewswire
·
April 3, 2025
CLEVELAND, April 03, 2025 (GLOBE NEWSWIRE) -- The hair loss industry is at a tipping point. A recent Wall Street Journal exposé has reignited concerns about the severe and long-term side effects of finasteride, the FDA-approved drug for male pattern …
Unlock the Future of Cybersecurity at the OpenSSL Conference 2025 in Prague
GlobeNewswire
·
April 3, 2025
NEWARK, Del., April 03, 2025 (GLOBE NEWSWIRE) -- The OpenSSL Corporation and the OpenSSL Foundation are proud to announce the OpenSSL Conference 2025, taking place from October 7 to 9, 2025, in Prague, Czech Republic, at the Vienna House by Wyndham …
FibroBiologics annonce des progrès scientifiques suite à la confirmation des résultats relatifs à la réparation de tissus cérébraux
GlobeNewswire
·
April 3, 2025
HOUSTON, 03 avr. 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq : FBLG), ou « FibroBiologics », une société de biotechnologie au stade clinique détenant plus de 240 brevets délivrés et en instance portant sur le développement de thérapies et de …